Application of liposomes to the treatment of liver metastasis

Advanced Drug Delivery Reviews

Volumn 24, Issue 2-3, 1997, Pages 331-335

  Konno, Hiroyuki ^a   Maruo, Yuji ^a   Matsuda, Iwao ^a   Tanaka, Tatsuo ^a   Baba, Shozo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adriamycin (doxorubicin); liposome; liver metastases

Indexed keywords

BIOMEDICAL ENGINEERING; CHEMICAL MODIFICATION; CHOLESTEROL; CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; DRUG PRODUCTS; ENCAPSULATION; LIPIDS; ONCOLOGY; PATIENT TREATMENT;

ADRIAMYCIN; COMBINATION THERAPY; GASTROINTESTINAL CANCER; LIPOSOMES; LIVER METASTASIS; THERAPEUTIC EFFECT; TUMOR NECROSIS FACTOR;

DRUG THERAPY;

CHOLESTEROL; DOXORUBICIN; FLUOROURACIL; LIPOSOME; MITOMYCIN C; PHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER GRAFT; CHEMICAL MODIFICATION; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; ENCAPSULATION; FEMALE; HUMAN; HYDRATION; INTERMETHOD COMPARISON; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STOMACH CANCER; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0343487632     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00475-9     Document Type: Conference Paper

References (10)

1. Hughes, K.S. (1988) Registry of Hepatic Metastases Resection of the liver for colorectal carcinoma metastases: a multi-institution study of indications for resection. Surgery, 103, 278-288.
2. Takahashi, K., Mori, T. and Takahashi, T. ( 1991 ) Evaluation of continuous intra-arterial infusion chemotherapy after hepatic resection for colorectal metastases. Jpn. J. Cancer. Chemother., 18, 1935-1939.
3. Mayer, L.D., Balley, M.D., Hope, M.J. and Cullis, P.R. (1985 ) Uptake of antineoplastic agents into large unilammellar vesicles in response to membrane potential. Biochem. Biophys. Acta, 816, 294-302.
4. Mayer, L.D., Bailey, M.D. and Cullis, P.R. ( 1986) Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochem. Biophys. Acta, 857, 123-126.
5. Haranaka, K., Satomi, N. and Sakurai, A. (1984) Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int. J. Cancer, 34, 263-267.
6. Cowens, J.W., Creaven, P.J., Greco, W.R., Brenner, D.E., Tung, Y., Ostro, M., Pilkiewicz, F., Ginsberg, R. and Petrelli, N. (1993) Initial clinical (Phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res., 53, 2796-2802.
7. Gabizon, A., Peretz, T., Sulkes, A., Amselem, S., Ben-Yosef, R., Ben-Baruch, N., Catane, R., Biran. S. and Barenholz, Y. (1989) Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur. J. Cancer Clin. Oncol., 25, 1795-1803.
8. Treat, J., Greenspan, A., Forst, D., Sanchez, J.A., Ferrans, V.J., Potkul, L.A., Woolley, P.V. and Rahman, A. (1990) Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J. Natl. Cancer Inst., 82, 1706-1710.
9. Rahman, A., Treat, J., Roh, J.K., Potkul, L.A., Alvord, W.G., Forst, D. and Woolley, P.V. (1990) A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin. J. Clin. Oncol., 8, 1093-1100.
10. Owen, R.R., Sells, R.A., Gilmore, I.T., New, R.R. and Stringer, R.E. (1992) A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancy. Anticancer Drugs, 3, 101-107.